A controversial 2020 study that claimed the malaria drug hydroxychloroquine showed promise for treating COVID-19 has finally been retracted, after sparking widespread criticism from scientists ever since its publication. The study was originally published online in the International Journal of Antimicrobial Agents on March 20, 2020. With a small sample size of just 36 total … [Read more...] about Second Most-Cited Paper To Ever Be Withdrawn Finally Retracted After 4-Year Controversy
clinical trials
Newly Approved Schizophrenia Drug Could Eventually Treat Alzeimer’s-Related Psychosis
A groundbreaking development in the field of neurology could offer hope to millions of Alzheimer's patients worldwide. A newly approved drug, Cobenfy, initially designed to treat schizophrenia, is now being explored for its potential to alleviate the debilitating symptoms of Alzheimer's-related psychosis. The Science Behind Cobenfy Cobenfy, a combination of Xanomeline and … [Read more...] about Newly Approved Schizophrenia Drug Could Eventually Treat Alzeimer’s-Related Psychosis